
Tag: ALK-positive research
- ALK Experts
- ALK International
- ALK Positive News
- Clinical Trials
- Government
- Living with ALK+
- Nutrition
- Patient & Care Partner Stories
- Powered By Patients
- Recipes
- Research
-

ALKtALK: AI in your Corner: One Advocate’s Guide to Using AI Tools for Your Cancer Care.
You asked and we listened- this is yet another ALKtALK you won’t want to miss! We’ll be joined by a fellow ALK-positive patient who shares how AI tools help him manage his cancer care- from preparing for appointments to understanding scan reports and side effect management. With prior professional experience navigating privacy and security tradeoffs,…
-

ALKtALK: Live from ASCO with Dr. Christine Lovly!
Join ALKtALK to hear from ALK Positive’s Director of Research and Clinical Affairs. Dr. Ken Culver will provide updates on the essential work of ALK Positive’s Medical Committees, the research projects you helped power, and the bold priorities ahead.
-

ALKtALK with Dr. Ken Culver
Join ALKtALK to hear from ALK Positive’s Director of Research and Clinical Affairs. Dr. Ken Culver will provide updates on the essential work of ALK Positive’s Medical Committees, the research projects you helped power, and the bold priorities ahead.
-

Live from ASCO with Break Through Cancer
🚨 LIVE from ASCO – You’re Invited! 🚨 We’re kicking off ALK Positive Awareness Month 2025 with a special ALKtALK, featuring a research update from Break Through Cancer and a look at what’s ahead. 🎙 Featuring: Jesse Boehm, PhD📅 Sunday, June 1🕖 7:00 PM ET📍 Streaming on Zoom This year’s Powered by Patients campaign is…
-

Let’s talk meds, interactions, and whole-person care in thoracic oncology.Join ALKtALK for a discussion on Managing Meds & More: The Pharmacist’s Role in ALK+ Cancer
-

Dr. Ken Culver, ALK Positive Director of Research and Clinical Affairs
Join ALKtALK to hear from ALK Positive’s Director of Research and Clinical Affairs. Dr. Ken Culver will provide updates on the essential work of ALK Positive’s Medical Committees, the research projects you helped power, and the bold priorities ahead.
